Abstract:This scoping review aims to identify and evaluate the landscape of Polygenic Risk Score (PRS)-based methods for genomic prediction from 2013 to 2023, highlighting their advancements, key concepts, and existing gaps in knowledge, research, and technology. Over the past decade, various PRS-based methods have emerged, each employing different statistical frameworks aimed at enhancing prediction accuracy, processing speed and memory efficiency. Despite notable advancements, challenges persist, including unrealistic assumptions regarding sample sizes and the polygenicity of traits necessary for accurate predictions, as well as limitations in exploring hyper-parameter spaces and considering environmental interactions. We included studies focusing on PRS-based methods for risk prediction that underwent methodological evaluations using valid approaches and released computational tools/software. Additionally, we restricted our selection to studies involving human participants that were published in English language. This review followed the standard protocol recommended by Joanna Briggs Institute Reviewer's Manual, systematically searching Ovid MEDLINE, Ovid Embase, Scopus and Web of Science databases. Additionally, searches included grey literature sources like pre-print servers such as bioRxiv, and articles recommended by experts to ensure comprehensive and diverse coverage of relevant records. This study identified 34 studies detailing 37 genomic prediction methods, the majority of which rely on linkage disequilibrium (LD) information and necessitate hyper-parameter tuning. Nine methods integrate functional/gene annotation, while 12 are suitable for cross-ancestry genomic prediction, with only one considering gene-environment (GxE) interaction. While some methods require individual-level data, most leverage summary statistics, offering flexibility. Despite progress, challenges remain. These include computational complexity and the need for large sample sizes for high prediction accuracy. Furthermore, recent methods exhibit varying effectiveness across traits, with absolute accuracies often falling short of clinical utility. Transferability across ancestries varies, influenced by trait heritability and diversity of training data, while handling admixed populations remains challenging. Additionally, the absence of standard error measurements for individual PRSs, crucial in clinical settings, underscores a critical gap. Another issue is the lack of customizable graphical visualization tools among current software packages. While genomic prediction methods have advanced significantly, there is still room for improvement. Addressing current challenges and embracing future research directions will lead to the development of more universally applicable, robust, and clinically relevant genomic prediction tools.

The personal and clinical utility of polygenic risk scores

Polygenic risk scores: from research tools to clinical instruments

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

Clinical genetic counseling and translation considerations for polygenic scores in personalized risk assessments: A Practice Resource from the National Society of Genetic Counselors

Polygenic scores and their applications in kidney disease

Clinical use of current polygenic risk scores may exacerbate health disparities

Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field

Polygenic Risk Scores: The Next Step for Improved Risk Stratification in Coronary Artery Disease?

Genetic risk prediction in complex disease

Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores

Systems biology approaches to utilise polygenic risk scores for chronic diseases

A perspective on genetic and polygenic risk scores—advances and limitations and overview of associated tools

Ethical, legal, and social implications of genetic risk prediction for multifactorial disease: a narrative review identifying concerns about interpretation and use of polygenic scores

Advancements and limitations in polygenic risk score methods for genomic prediction: a scoping review

Implementing polygenic risk scores in the clinic

Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues

Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers

Recent advances in polygenic scores: translation, equitability, methods and FAIR tools

Taking the risk. A systematic review of ethical reasons and moral arguments in the clinical use of polygenic risk scores

Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer

Genomic Prediction of Complex Disease Risk